510(k) K163085

Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack by Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC — Product Code OZN

K163085 is an FDA 510(k) premarket notification submitted by Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC for the device "Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack". The FDA issued a decision of Substantially Equivalent on Feb 14, 2017. The device falls under product code OZN (C. Difficile Toxin Gene Amplification Assay), a Class II device regulated under 21 CFR 866.3130.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Feb 14, 2017
Date Received
Nov 3, 2016
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
C. Difficile Toxin Gene Amplification Assay
Device Class
Class II
Regulation Number
866.3130
Review Panel
MI
Submission Type
510(k)

Amplification assay for the detection of c. Difficile toxin genes from stool specimens of symptomatic patients.

Need the full FDA record for Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K163085. Report a data issue: hello@regdatalab.com.